ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Cannara Biotech Inc

Cannara Biotech Inc (LOVE)

0.86
0.06
(7.50%)
Closed January 13 4:00PM
Advanced chart

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.86
Bid
0.84
Ask
0.87
Volume
49,500
0.80 Day's Range 0.86
0.52 52 Week Range 1.04
Market Cap
Previous Close
0.80
Open
0.80
Last Trade
500
@
0.86
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
27,648
Shares Outstanding
90,018,000
Dividend Yield
-
PE Ratio
12.03
Earnings Per Share (EPS)
0.07
Revenue
82.15M
Net Profit
6.44M

About Cannara Biotech Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Saint-laurent, Quebec, Can
Founded
-
Cannara Biotech Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker LOVE. The last closing price for Cannara Biotech was $0.80. Over the last year, Cannara Biotech shares have traded in a share price range of $ 0.52 to $ 1.04.

Cannara Biotech currently has 90,018,000 shares outstanding. The market capitalization of Cannara Biotech is $72.01 million. Cannara Biotech has a price to earnings ratio (PE ratio) of 12.03.

LOVE Latest News

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023.Robust growth in Q4 over Q3 2024, with total...

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis...

Cannara Biotech Reports Q3 2024 Financial Results

Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased...

Cannara Biotech publie ses résultats financiers pour le deuxième trimestre de 2024

Cannara Biotech publie ses résultats financiers pour le deuxième trimestre de 2024 Canada NewsWire MONTRÉAL, le 29 avril 2024 Les revenus nets ont augmenté pour atteindre 19,7...

Cannara Biotech annonce des résultats records pour le premier trimestre de 2024 : Croissance robuste continue et expansion du marché

Cannara Biotech annonce des résultats records pour le premier trimestre de 2024 : Croissance robuste continue et expansion du marché Canada NewsWire MONTRÉAL, le 30 janv. 2024 Des...

Cannara Biotech annonce l'engagement d'Independent Trading Group (ITG) pour la prestation de services de teneur de marché

Cannara Biotech annonce l'engagement d'Independent Trading Group (ITG) pour la prestation de services de teneur de marché Canada NewsWire MONTRÉAL, le 8 janv. 2024 MONTRÉAL, le...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.067.50.80.860.74502280.7866191CS
40.1521.12676056340.710.860.66354020.76197052CS
120.2234.3750.640.860.58276480.72870991CS
260.230.3030303030.660.860.52208650.69419961CS
520.044.878048780490.821.040.52218380.77080772CS
1560.7355880.1251.150.085622660.24462122CS
2600.7437.50.161.150.0851250400.19117078CS

LOVE - Frequently Asked Questions (FAQ)

What is the current Cannara Biotech share price?
The current share price of Cannara Biotech is $ 0.86
How many Cannara Biotech shares are in issue?
Cannara Biotech has 90,018,000 shares in issue
What is the market cap of Cannara Biotech?
The market capitalisation of Cannara Biotech is CAD 72.01M
What is the 1 year trading range for Cannara Biotech share price?
Cannara Biotech has traded in the range of $ 0.52 to $ 1.04 during the past year
What is the PE ratio of Cannara Biotech?
The price to earnings ratio of Cannara Biotech is 12.03
What is the cash to sales ratio of Cannara Biotech?
The cash to sales ratio of Cannara Biotech is 0.94
What is the reporting currency for Cannara Biotech?
Cannara Biotech reports financial results in CAD
What is the latest annual turnover for Cannara Biotech?
The latest annual turnover of Cannara Biotech is CAD 82.15M
What is the latest annual profit for Cannara Biotech?
The latest annual profit of Cannara Biotech is CAD 6.44M
What is the registered address of Cannara Biotech?
The registered address for Cannara Biotech is 333 D��CARIE, SUITE 200, SAINT-LAURENT, QUEBEC, H4N 3M9
What is the Cannara Biotech website address?
The website address for Cannara Biotech is www.cannara.ca
Which industry sector does Cannara Biotech operate in?
Cannara Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SQGSpackman Equities Group Inc
$ 3.50
(354.55%)
59.45k
KLMKermode Resources Ltd
$ 0.01
(100.00%)
1.42M
GNFIGenifi Inc
$ 0.01
(100.00%)
2k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
JADEJade Leader Corp
$ 0.04
(60.00%)
177k
AJAAJA Health and Wellness Inc
$ 0.035
(-53.33%)
2k
BYM.HBaymount Incorporated
$ 0.005
(-50.00%)
1,000
ETUE2gold Inc
$ 0.005
(-50.00%)
12.29k
ENTGEntourage Health Corp
$ 0.005
(-50.00%)
16.04k
WWA.PWhitewater Acquisition Corp
$ 0.14
(-48.15%)
5k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
QNCQuantum Emotion Corp
$ 0.90
(-19.64%)
4.37M
GPUSAlset AI Ventures Inc
$ 0.185
(-11.90%)
4.1M
RHCRoyal Helium Ltd
$ 0.02
(0.00%)
3.47M
THRMTherma Bright Inc
$ 0.04
(-20.00%)
2.71M

LOVE Financials

Financials

Discussion

View Full Feed
Shawonsarker84 Shawonsarker84 5 minutes ago
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 7 minutes ago
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 10 minutes ago
Oh noooooo.....
FNMA
StockItOut StockItOut 12 minutes ago
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 31 minutes ago
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 31 minutes ago
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL
Louinjaxxx Louinjaxxx 34 minutes ago
The reversal on Friday just reflects the entire market downturn on Friday.
AXXA
Steady_T Steady_T 36 minutes ago
That sounds pretty optimistic to me. I'd think that the RA would like to see some data on other cancers before such a broad scope label.
NWBO
boi568 boi568 38 minutes ago
I think he edited the question he asked to make it look neutral.
AVXL
Louinjaxxx Louinjaxxx 38 minutes ago
So the extra 5 to 6 million shares will help you pay the taxes on you gain?  That makes sense.
AXXA
sunspotter sunspotter 45 minutes ago
Dr. Jamil should know that once it is established that the primary endpoint has not been reached, it is widely recognised that it is not valid statistically to declare secondary endpoints and other sub-analyses as having reached statistical significance.

It’s a (not very) sophisticat
GALT
nowwhat2 nowwhat2 51 minutes ago
The Overhead Trendline, The 2.50 Level, The Overall Crypto Sector......

Boy.......what ppl steer clear of considering here is a real mindblower.......


https://investorshub.advfn.com/uimage/uploads/2025/1/13/rmobiXRP_!_12_45d_6pm_GLITCH_OHTL_250_SUMMARY.jpg
XRPUSD
PickStocks PickStocks 53 minutes ago
You contradict yourself......" style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"IF YOU owned P's, K's, or uq's ? ... the DTC Knows It' ... and, the DTC Knows EXACTLY How Many P's, K's, or uq's ... YO
COOP
Malolo Malolo 54 minutes ago
Hello, I'm a newbie at AIM. Wondering if someone could recommend or provide a good spreadsheet?
roncderu@gmail.com.
OPennyS OPennyS 57 minutes ago
If the predictions are correct it is going to be an interesting week.
VXX
Hoghead7 Hoghead7 59 minutes ago
PORTHOS still on schedule. Seems like spring/summer commissioning
https://www.linkedin.com/posts/porthos-co2_porthos-porthosco-co2-activity-7282763014376677376-qnb-?utm_source=share&utm_medium=member_android

https://www.linkedin.com/posts/activity-7275803191202447360-EX6x?utm
FCEL
mining hound mining hound 1 hour ago
Hi all, thanks for happy new year wishes and I wish the same for all here too!
HLLXF
gfp927z gfp927z 1 hour ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
gfp927z gfp927z 1 hour ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
georgebailey georgebailey 1 hour ago
Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
NWBO
Birdbrain Ideas Birdbrain Ideas 1 hour ago
If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
AMRN
devil dog 96 devil dog 96 1 hour ago
In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
ATMH
3jack 3jack 1 hour ago
We will persevere!
AVXL
gfp927z gfp927z 1 hour ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG

Your Recent History

Delayed Upgrade Clock